Diseases we research

The Garvan Institute has more than 600 scientists working together across six research areas. We use the latest genomic technologies to study disease and identify new and better treatments.

Cancer research

The Cancer Research team aims to identify the genetic, epigenetic, and molecular drivers behind the development and progression of cancer. These discoveries help to find more accurate ways to diagnose cancer and provide more effective personalised treatment.

Neuroscience research

Garvan’s Neuroscience researchers seek to understand the molecular mechanisms that underpin the capacity of the human brain to learn, think and function. This includes the ways nerve cells communicate with each other and what goes wrong in disorders such as neurodegenerative disease.

Bone biology research

The Osteoporosis and Bone Biology team focuses on the links between genetic, hormonal and lifestyle influences that can lead to conditions like osteoporosis. They also study tumour-induced bone diseases with the aim of preventing tumour growth in bone.

Immunology research

Garvan’s immunology research looks at how the immune system protects the body and what goes wrong when disease occurs. This can help us combat immune disorders, and harness the immune system’s power to fight diseases like cancer.

Diabetes and metabolism research

This research looks at the global rise of diabetes and obesity, and the part genetics and changes in our lifestyle and diet have played in this. Our teams are particularly interested in how fat and sugar contributes to diabetes, and how insulin fails to work properly in sufferers.